title: Phospholipid metabolites, prognosis and proliferation in human breast carcinoma.
abstract: The content of the phospholipid metabolites, phosphocholine, phosphoethanolamine, glycerophosphorylcholine and glycerophosphorylethanolamine was measured in chemical extracts from 46 human breast carcinoma using 31P NMR spectroscopy. Some patients had received therapy prior to tumour resection. The data were therefore stratified into two groups: (i) all tumours; and (ii) untreated tumours. Three indices of tumour proliferation i.e., mitotic index, Ki67 and S-phase fraction were determined on tissue from the same tumours and were found not to correlate with the content of any of these metabolites. In addition oestrogen-receptor status and density, tumour grade and DNA ploidy were obtained on some tumours. The phosphocholine content was higher in high grade tumours when compared with low grade tumours. There was no apparent relationship between DNA ploidy and the content of any of these metabolites. Glycerophosphorylcholine content of oestrogen-receptor positive tumours correlated with receptor density. However, there was no significant difference between receptor positive and negative tumours in the content of any of the phospholipid metabolites measured.
authors.affiliation: Department of Nuclear Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
authors.forename: T A
authors.initials: TA
authors.lastname: Smith
authors.forename: C
authors.initials: C
authors.lastname: Bush
authors.forename: C
authors.initials: C
authors.lastname: Jameson
authors.forename: J C
authors.initials: JC
authors.lastname: Titley
authors.forename: M O
authors.initials: MO
authors.lastname: Leach
authors.forename: D E
authors.initials: DE
authors.lastname: Wilman
authors.forename: V R
authors.initials: VR
authors.lastname: McCready
mesh_terms: D000782:Aneuploidy; D001943:Breast Neoplasms / Q000737:chemistry* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D004273:DNA, Neoplasm / Q000032:analysis; D004983:Ethanolamines / Q000032:analysis; D005260:Female; D005997:Glycerylphosphorylcholine / Q000032:analysis; D006801:Humans; D019394:Ki-67 Antigen; D009682:Magnetic Resonance Spectroscopy; D008940:Mitotic Index; D009363:Neoplasm Proteins / Q000032:analysis; D009687:Nuclear Proteins / Q000032:analysis; D010714:Phosphatidylethanolamines / Q000032:analysis; D010743:Phospholipids / Q000032:analysis*; D010767:Phosphorylcholine / Q000032:analysis; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D016196:S Phase; D014020:Tissue Extracts
chemical_list: D004273:DNA, Neoplasm; D004983:Ethanolamines; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D011960:Receptors, Estrogen; D014020:Tissue Extracts; D010767:Phosphorylcholine; C002449:glycerophosphoethanolamine; D005997:Glycerylphosphorylcholine; C005448:phosphorylethanolamine